[Federal Register Volume 89, Number 178 (Friday, September 13, 2024)]
[Notices]
[Pages 74995-74996]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-20789]
=======================================================================
-----------------------------------------------------------------------
INTERNATIONAL TRADE COMMISSION
[Investigation No. 337-TA-1417]
Certain Hydrodermabrasion Systems and Components Thereof III;
Notice of Institution of Investigation
AGENCY: U.S. International Trade Commission.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given that a complaint was filed with the
U.S. International Trade Commission on August 8, 2024, under section
337 of the Tariff Act of 1930, as amended, on behalf of HydraFacial LLC
f/k/a Edge Systems LLC of Long Beach, California. Supplements were
filed on August 23 and 28, 2024. The complaint, as supplemented,
alleges violations of section 337 based upon the importation into the
United States, the sale for importation, and the sale within the United
States after importation of certain hydrodermabrasion systems and
components thereof by reason of the infringement of certain claims of
U.S. Patent No. 11,446,477 (``the '477 patent''). The complaint further
alleges that an industry in the United States exists as required by the
applicable Federal Statute. The complainant requests that the
Commission institute an investigation and, after the investigation,
issue a limited exclusion order and a cease and desist order.
ADDRESSES: The complaint, except for any confidential information
contained therein, may be viewed on the Commission's electronic docket
(EDIS) at https://edis.usitc.gov. For help accessing EDIS, please email
[email protected]. Hearing impaired individuals are advised that
information on this matter can be obtained by contacting the
Commission's TDD terminal on (202) 205-1810. Persons with mobility
impairments who will need special assistance in gaining access to the
Commission should contact the Office of the Secretary at (202) 205-
2000. General information concerning the Commission may also be
obtained by accessing its internet server at https://www.usitc.gov.
FOR FURTHER INFORMATION CONTACT: Susan Orndoff, The Office of Docket
Services, U.S. International Trade Commission, telephone (202) 205-
1802.
SUPPLEMENTARY INFORMATION:
Authority: The authority for institution of this investigation is
contained in section 337 of the Tariff Act of 1930, as amended, 19
U.S.C. 1337, and in section 210.10 of the Commission's Rules of
Practice and Procedure, 19 CFR 210.10 (2024).
Scope of Investigation: Having considered the complaint, the U.S.
International Trade Commission, on September 9, 2024, ordered that--
(1) Pursuant to subsection (b) of section 337 of the Tariff Act of
1930, as amended, an investigation be instituted to determine whether
there is a violation of subsection (a)(1)(B) of section 337 in the
importation into the United States, the sale for importation, or the
sale within the United States after importation of certain products
identified in paragraph (2) by reason of infringement of one or more of
claims 1-5 and 7-20 of the '477 patent, and whether an industry in the
United States exists as required by subsection (a)(2) of section 337;
(2) Pursuant to section 210.10(b)(1) of the Commission's Rules of
Practice and Procedure, 19 CFR 210.10(b)(1), the plain language
description of the accused products or category of accused products,
which defines the scope of the investigation, is ``systems and
subassemblies for skin treatment through mechanical and/or fluid-based
abrasion or exfoliation'';
(3) For the purpose of the investigation so instituted, the
following are hereby named as parties upon which this notice of
investigation shall be served:
(a) The complainant is/are: HydraFacial LLC f/k/a Edge Systems LLC,
2165 E. Spring St., Long Beach, California 90806.
(b) The respondents are the following entities alleged to be in
violation of section 337, and are the parties upon which the complaint
is to be served:
Luvo Medical Technologies Inc., 125 Fleming Drive, Cambridge, Ontario,
N1T 2B8, Canada
Clarion Medical Technologies, Inc., 125 Fleming Drive, Cambridge,
Ontario, N1T 2B8, Canada
Healthcare Markets, Inc. d/b/a Powered by MRP, 2720 Rasmussen Rd. A3,
Park City, Utah 84098
Medical Purchasing Resource, LLC, 5026 Cardinal Court, Little Elm, TX
75068
Bio-Infusions USA Inc., 9190 Oakhurst Road, Suite 2, Seminole, FL 33776
MIRAmedtech UG, Habightweg 3-5, 75245 Neulingen, Germany
eMIRAmed USA, LLC, 38 Tesla, Irvine, CA 92618
MIRAmedtech SP. Z.O.O., Powsta[nacute]c[oacute]w [Sacute]l[aogon]skich
89A/235, 01-355 Warsaw, Poland
(4) For the investigation so instituted, the Chief Administrative
Law Judge, U.S. International Trade Commission,
[[Page 74996]]
shall designate the presiding Administrative Law Judge.
The Office of Unfair Import Investigations will not participate as
a party in this investigation.
Responses to the complaint and the notice of investigation must be
submitted by the named respondents in accordance with section 210.13 of
the Commission's Rules of Practice and Procedure, 19 CFR 210.13.
Pursuant to 19 CFR 201.16(e) and 210.13(a), as amended in 85 FR 15798
(March 19, 2020), such responses will be considered by the Commission
if received not later than 20 days after the date of service by the
complainant of the complaint and the notice of investigation.
Extensions of time for submitting responses to the complaint and the
notice of investigation will not be granted unless good cause therefor
is shown.
Failure of a respondent to file a timely response to each
allegation in the complaint and in this notice may be deemed to
constitute a waiver of the right to appear and contest the allegations
of the complaint and this notice, and to authorize the administrative
law judge and the Commission, without further notice to the respondent,
to find the facts to be as alleged in the complaint and this notice and
to enter an initial determination and a final determination containing
such findings, and may result in the issuance of an exclusion order or
a cease and desist order or both directed against the respondent.
By order of the Commission.
Issued: September 9, 2024.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2024-20789 Filed 9-12-24; 8:45 am]
BILLING CODE 7020-02-P